Oncology

A novel artificial intelligence (AI) framework called AutoRadAI has demonstrated strong diagnostic performance in detecting extracapsular extension (ECE) in prostate cancer, a key prognostic factor that can significantly impact treatment planning and surgical outcomes.

In the high-stakes landscape of cancer treatment where healthcare professionals rely on cost-effectiveness analyses to guide decisions adverse event costs may be throwing off the equation.

A new study sheds light on the hidden cardiovascular risks lurking in the critical first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).

Prostate cancer survivors face a long-term threat that often goes undetected, a third primary cancer, according to new findings that highlight an under-recognized but serious risk with significant survival implications.

A new national study published ahead of print in JCO Oncology Practice reveals a steady increase in time to treatment initiation (TTI) across all 30 of the most prevalent cancer types, with early-stage diagnoses now a major driver of these delays.

n a new 5-year follow-up study exploring diagnostic tools for adenocarcinoma of the esophagogastric junction (AEG), PET combined with MRI (PET/MRI) has shown strong potential for predicting long-term survival.

Cancer survivors face a significantly increased risk of cardiovascular mortality, according to a major nationwide study in Japan that highlights key differences in cardiovascular risk across cancer types and specific heart-related diseases.

At the 2025 AACR Annual Meeting, researchers unveiled an AI-driven model that significantly improves the early detection of cancer cachexia by analyzing routinely collected diagnostic imaging and clinical data.